These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9619761)

  • 1. Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients.
    Beale P; Judson I; Hanwell J; Berry C; Aherne W; Hickish T; Martin P; Walker M
    Cancer Chemother Pharmacol; 1998; 42(1):71-6. PubMed ID: 9619761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors.
    Grem JL; Sorensen JM; Cullen E; Takimoto CH; Steinberg SM; Chen AP; Hamilton JM; Arbuck SG; McAtee N; Lawrence D; Goldspiel B; Johnston PG; Allegra CJ
    Clin Cancer Res; 1999 Sep; 5(9):2381-91. PubMed ID: 10499608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and preclinical pharmacokinetics of raltitrexed.
    Clarke SJ; Beale PJ; Rivory LP
    Clin Pharmacokinet; 2000 Dec; 39(6):429-43. PubMed ID: 11192475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase I study of raltitrexed (ZD-1694)].
    Horikoshi N; Aiba K; Fukuoka M; Akazawa S; Sakata Y; Furuse K; Kanamaru R; Kudoh S; Konishi T; Kurihara M; Niitani H; Furue H; Tsukagoshi S; Taguchi T; Yoshida S; Ota K; Kotake T; Wakui A
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2075-84. PubMed ID: 9838910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model.
    Widemann BC; Balis FM; Godwin KS; McCully C; Adamson PC
    Cancer Chemother Pharmacol; 1999; 44(6):439-43. PubMed ID: 10550563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).
    Judson I; Maughan T; Beale P; Primrose J; Hoskin P; Hanwell J; Berry C; Walker M; Sutcliffe F
    Br J Cancer; 1998 Nov; 78(9):1188-93. PubMed ID: 9820178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors.
    Clarke SJ; Hanwell J; de Boer M; Planting A; Verweij J; Walker M; Smith R; Jackman AL; Hughes LR; Harrap KR; Kennealey GT; Judson IR
    J Clin Oncol; 1996 May; 14(5):1495-503. PubMed ID: 8622063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion.
    Rafi I; Taylor GA; Calvete JA; Boddy AV; Balmanno K; Bailey N; Lind M; Calvert AH; Webber S; Jackson RC
    Clin Cancer Res; 1995 Nov; 1(11):1275-84. PubMed ID: 9815922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitor of thymidylate synthase, in patients with advanced solid malignancies.
    Schwartz G; Johnson TR; Goetz A; Burris H; Smetzer L; Lampkin T; Sailstad J; Hohneker JA; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2001 Jul; 7(7):1901-11. PubMed ID: 11448903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A late phase II study of raltitrexed (ZD 1694) in chemotherapy-naive patients with advanced colorectal cancer].
    Nishisho I; Kikkawa N; Ebata T; Osanai H; Ujiie S; Mitachi Y; Tsutsui M; Sawai K; Nishiguchi Y; Yasutake K; Wakasugi H; Wakui A
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):81-91. PubMed ID: 10660737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
    Sato A; Kurihara M; Horikoshi N; Aiba K; Kikkawa N; Shirouzu K; Mitachi Y; Sakata Y; Wakui A
    Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study.
    Horton TM; Blaney SM; Langevin AM; Kuhn J; Kamen B; Berg SL; Bernstein M; Weitman S
    Clin Cancer Res; 2005 Mar; 11(5):1884-9. PubMed ID: 15756014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinoma.
    François E; Hebbar M; Bennouna J; Mayeur D; Perrier H; Dorval E; Martin C; Bourgeois H; Barthélemy P; Douillard JY
    Oncology; 2005; 68(4-6):299-305. PubMed ID: 16020956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raltitrexed: optimism and reality.
    Wilson KS; Malfair Taylor SC
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1447-54. PubMed ID: 19863453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer.
    Romiti A; Tonini G; Santini D; Di Seri M; Masciangelo R; Mezi S; Verì A; Santuari L; Vincenzi B; Brescia A; Marchei P; Frati L; Tomao S
    Anticancer Res; 2002; 22(5):3071-6. PubMed ID: 12530045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.
    Avallone A; Di Gennaro E; Silvestro L; Iaffaioli VR; Budillon A
    Expert Opin Drug Saf; 2014 Jan; 13(1):113-29. PubMed ID: 24093908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).
    Galanis E; Goldberg R; Reid J; Atherton P; Sloan J; Pitot H; Rubin J; Adjei AA; Burch P; Safgren SL; Witzig TE; Ames MM; Erlichman C
    Ann Oncol; 2001 May; 12(5):701-7. PubMed ID: 11432631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer: a pilot study.
    Tsavaris N; Kosmas C; Vadiaka M; Kontos A; Fotia M; Angelopoulou A; Vrizidis N; Soulla M; Sougioultzis S; Koufos Ch
    Invest New Drugs; 2002 Feb; 20(1):133-6. PubMed ID: 12003191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia.
    Nutting C; Folkes A
    Clin Oncol (R Coll Radiol); 1999; 11(1):66. PubMed ID: 10194593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.